JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A4478 HLI 373

Summary: Hdm2 ubiquitin ligase (E3) inhibitor

<37.79 mg/mL
A4524 4-HQN

Summary: PARP inhibitor

≥7.4 mg/mL
A1337 U0126-EtOH
24 Citation

Target: MEK

Summary: MEK1/2 inhibitor

≥21.33 mg/mL
A5618 Daclatasvir (BMS-790052)

Target: HCV Proteases

Summary: HCV NS5A inhibitor

≥36.6 mg/mL
A8307 Crenolanib (CP-868596)
2 Citation

Target: FLT3|PDGFR

Summary: PDGFR-β inhibitor,potent and selective

≥22.2 mg/mL
A8448 INCB28060
2 Citation

Target: c-MET

Summary: C-Met inhibitor,ATP-competitive and novel

insoluble in EtOH; insoluble in H2O; ≥5.15 mg/mL
A8618 Palomid 529
2 Citation

Summary: PI3K/Akt/mTOR inhibitor

insoluble in EtOH; insoluble in H2O; ≥41 mg/mL
A8629 DBeQ

Target: P97 ATPase

Summary: P97 ATPase inhibitor

≥16 mg/mL
B2141 Calcitriol
5 Citation

Summary: Active metabolite of vitamin D3

insoluble in H2O; ≥20.83 mg/mL
B2227 BI-D1870
1 Citation

Target: p90 S6K

Summary: P90 RSK inhibitor,ATP-competitive and cell-permeable

insoluble in H2O; ≥19.55 mg/mL